The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 346:63-65 January 3, 2002 Number 1
NextNext

Postmenopausal Hormone-Replacement Therapy

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: In the July 5 issue of the Journal, Manson and Martin review the clinical controversies surrounding hormone-replacement therapy.1 The findings of the Heart and Estrogen/Progestin Replacement Study (HERS) suggest reasons to be cautious about the use of hormone-replacement therapy in women who are 65 years of age or older. Of 2763 women (mean age, 67 years) with established coronary heart disease, women who were randomly assigned to receive hormone-replacement therapy had an excess risk of one additional blood clot per 64 women and of one additional gallbladder operation per 69 women during a four-year period.2,3 Hormone-replacement therapy . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.